Mäkeläinen, Suvi, Hellsand, Minas, van Der Heiden, Anna Darlene, Andersson, Elina, Thorsson, Elina, Hoist, Bodil S., Häggström, Jens, Ljungvall, Ingrid, Mellersh, Cathryn, Hallböök, Finn, Andersson, Göran, Ekesten, Björn, Bergström, Tomas F., Mäkeläinen, Suvi, Hellsand, Minas, van Der Heiden, Anna Darlene, Andersson, Elina, Thorsson, Elina, Hoist, Bodil S., Häggström, Jens, Ljungvall, Ingrid, Mellersh, Cathryn, Hallböök, Finn, Andersson, Göran, Ekesten, Björn, and Bergström, Tomas F.
In golden retriever dogs, a 1 bp deletion in the canineTTC8gene has been shown to cause progressive retinal atrophy (PRA), the canine equivalent of retinitis pigmentosa. In humans,TTC8is also implicated in Bardet-Biedl syndrome (BBS). To investigate if the affected dogs only exhibit a non-syndromic PRA or develop a syndromic ciliopathy similar to human BBS, we recruited 10 affected dogs to the study. The progression of PRA for two of the dogs was followed for 2 years, and a rigorous clinical characterization allowed a careful comparison with primary and secondary characteristics of human BBS. In addition to PRA, the dogs showed a spectrum of clinical and morphological signs similar to primary and secondary characteristics of human BBS patients, such as obesity, renal anomalies, sperm defects, and anosmia. We used Oxford Nanopore long-read cDNA sequencing to characterize retinal full-lengthTTC8transcripts in affected and non-affected dogs, the results of which suggest that three isoforms are transcribed in the retina, and the 1 bp deletion is a loss-of-function mutation, resulting in a canine form of Bardet-Biedl syndrome with heterogeneous clinical signs.